Skip to main content

NextCure Inc

For the period ended Mar 31, 2024. Filed May 2, 2024.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Mar 31, 2024 · Filed May 2, 2024

NXTC$6.27+17.6%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Table of Contents

NextCure, Inc.

Form 10-Q

For the Quarter Ended March 31, 2024

TABLE OF CONTENTS

​ · ​
​​Page
PART I. FINANCIAL INFORMATION
Item 1.Financial Statements1
​Unaudited Condensed Balance Sheets as of March 31, 2024 and December 31, 20231
​Unaudited Condensed Statements of Operations and Comprehensive Loss for the Three Months Ended March 31, 2024 and 20232
​Unaudited Condensed Statements of Stockholders’ Equity for the Three Months Ended March 31, 2024 and 20233
​Unaudited Condensed Statements of Cash Flows for the Three Months Ended March 31, 2024 and 20234
​Notes to Unaudited Condensed Financial Statements5
Item 2.Management’s Discussion and Analysis of Financial Condition and Results of Operations15
Item 3.Quantitative and Qualitative Disclosures about Market Risk22
Item 4.Controls and Procedures22
Part II. OTHER INFORMATION
Item 1.Legal Proceedings23
Item 1A.Risk Factors23
Item 2.Unregistered Sales of Equity Securities and Use of Proceeds23
Item 3.Defaults Upon Senior Securities23
Item 4.Mine Safety Disclosures23
Item 5.Other Information23
Item 6.Exhibits24
SIGNATURES25

i

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.